103 related articles for article (PubMed ID: 2201822)
1. Tumor associated myelopoiesis inhibiting factors.
Olsson I; Olofsson T
Leuk Res; 1990; 14(8):715-6. PubMed ID: 2201822
[TBL] [Abstract][Full Text] [Related]
2. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
Olsson I; Olofsson T
Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cells in myeloid leukemia that produce leukemia associated inhibitor (LAI) and demonstration of LAI-producing cells in normal bone marrow.
Olofsson T; Nilsson E; Olsson I
Leuk Res; 1984; 8(3):387-96. PubMed ID: 6611459
[TBL] [Abstract][Full Text] [Related]
4. Genetic and oncogenic influences on myelopoiesis.
Moore MA
Haematol Blood Transfus; 1981; 26():237-42. PubMed ID: 6976288
[No Abstract] [Full Text] [Related]
5. Composition and function of the hemopoietic microenvironment in human myeloid leukemia.
Mayani H
Leukemia; 1996 Jun; 10(6):1041-7. PubMed ID: 8667639
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of bone marrow and extramedullary haemopoietic tissue in chronic myeloid leukemia.
Brandt L
Ser Haematol; 1975; 8(4):75-80. PubMed ID: 1071285
[No Abstract] [Full Text] [Related]
7. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.
Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M
J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells.
Olofsson T; Sallerfors B
Exp Hematol; 1987 Dec; 15(11):1163-7. PubMed ID: 3500070
[TBL] [Abstract][Full Text] [Related]
9. Suppression of normal hematopoiesis in acute leukemia: effect of leukemic cells on bone marrow stromal cells and hematopoietic progenitor cells.
Aoyagi M; Furusawa S; Waga K; Tsunogake S; Shishido H
Intern Med; 1994 May; 33(5):288-95. PubMed ID: 7949632
[TBL] [Abstract][Full Text] [Related]
10. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.
Orazi A; Kahsai M; John K; Neiman RS
Mod Pathol; 1996 Jan; 9(1):48-52. PubMed ID: 8821956
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-hematological comparisons in various forms of myelocytic leukemia in children].
Alekseev NA; Tiranova SA; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1980; (5):26-9. PubMed ID: 6930629
[No Abstract] [Full Text] [Related]
12. A challenge to solve "Lichtman's riddles".
Civin CI
Stem Cells; 2000; 18(5):iii. PubMed ID: 11007927
[No Abstract] [Full Text] [Related]
13. Hematon, a multicellular functional unit in normal human bone marrow: structural organization, hemopoietic activity, and its relationship to myelodysplasia and myeloid leukemias.
Blazsek I; Misset JL; Benavides M; Comisso M; Ribaud P; Mathé G
Exp Hematol; 1990 May; 18(4):259-65. PubMed ID: 2182330
[TBL] [Abstract][Full Text] [Related]
14. Suppression of normal hematopoiesis during acute leukemias.
Najman A; Kobari L; Khoury E; Baillou CL; Lemoine F; Guigon M
Ann N Y Acad Sci; 1991; 628():140-7. PubMed ID: 2069293
[No Abstract] [Full Text] [Related]
15. Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor.
Mayani H; Guilbert LJ; Clark SC; Belch AR; Janowska-Wieczorek A
Exp Hematol; 1992 Oct; 20(9):1077-84. PubMed ID: 1468541
[TBL] [Abstract][Full Text] [Related]
16. Dock2 participates in bone marrow lympho-hematopoiesis.
Kikuchi T; Kubonishi S; Shibakura M; Namba N; Matsui T; Fukui Y; Tanimoto M; Katayama Y
Biochem Biophys Res Commun; 2008 Feb; 367(1):90-6. PubMed ID: 18157938
[TBL] [Abstract][Full Text] [Related]
17. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis].
Morozova VT
Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126
[No Abstract] [Full Text] [Related]
18. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
[TBL] [Abstract][Full Text] [Related]
20. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus.
Broxmeyer HE; Ralph P; Gilbertson S; Margolis VB
Cancer Res; 1980 Nov; 40(11):3928-33. PubMed ID: 6258770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
